Join
Live feed
·
INSIDERFilingvia Quantisnow
Palvella Therapeutics Inc. logo

Director Jenkins George M bought $500,000 worth of shares (4,000 units at $125.00), increasing direct ownership by 2% to 187,171 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PVLA (Palvella Therapeutics Inc.) and more on Quantisnow.